Invasight

Zürich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

Jun 2022

Seed

Top Investors

HTGF (High-Tech Gruenderfonds)Verve VenturesZürcher Kantonal BankVenture KickWille Finance

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Invasight's investors?

Invasight's investors include HTGF (High-Tech Gruenderfonds), Verve Ventures, Zürcher Kantonal Bank, Venture Kick, Wille Finance.

Where is Invasight headquartered?

Invasight is headquartered in Zürich, Switzerland.

What does Invasight do?

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

What stage is Invasight at?

Invasight is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 7, 2022.

MLA

"Invasight — Funding & Investors." VCBacked, June 7, 2022, https://www.vcbacked.co/company/invasight. Accessed July 1, 2026.

APA

VCBacked. (2022). Invasight — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/invasight

Wikipedia (cite web)

{{cite web |title=Invasight — Funding & Investors |url=https://www.vcbacked.co/company/invasight |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 7, 2022.